EUVIMEDEUVIMED entdecken
Open Access

Pulmonary vascular remodeling in Fra-2 transgenic mice is driven by type 2 inflammation and accompanied by pulmonary vascular hyperresponsiveness

Anna Birnhuber iD, Valentina Biasin iD, Pritesh P Jain, Grzegorz Kwiatkowski, Ekaterina Boiarina, Jochen Wilhelm iD, Katharina Ahrens iD, Chandran Nagaraj, Andrea Olschewski iD, Martin Witzenrath, Stefan Chlopicki iD, Leigh M Marsh iD und 2 weitere

American Journal of Physiology-Lung Cellular and Molecular Physiology · 01.03.2025 · 328 (3) · L413-L429

DOI: 10.1152/ajplung.00274.2024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Physiology-Lung Cellular and Molecular Physiology, erschienen am 01.03.2025. Verfasst von Anna Birnhuber und 13 weiteren Autor:innen. Beteiligte Einrichtung: Ludwig Boltzmann Institute for Lung Vascular Research Graz, Graz, Austria. Hauptthemen laut MEDLINE: Vascular Remodeling, Fos-Related Antigen-2, Pulmonary Artery, Inflammation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: European Respiratory Society (ERS), Austrian Science Fund (FWF), Austrian Science Fund FWF.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In patients suffering from systemic sclerosis (SSc), pulmonary arterial hypertension (PAH) is a life-threatening complication linked to immune dysregulation. Preclinical analyses in Fos-related antigen-2 (Fra-2) transgenic (TG) mice, a model of SSc-PAH, identify type 2 inflammation as a key driver of vascular remodeling. Anti-inflammatory treatment targeting type 2 inflammation via IL-13 neutralizing antibodies improved pulmonary vascular remodeling. Thus, type 2-specific anti-inflammatory treatment may be a promising therapeutic approach in SSc-PAH.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vascular RemodelingFos-Related Antigen-2Pulmonary ArteryInflammationHypertension, PulmonaryLungAnimalsMice, TransgenicMiceHumansMyocytes, Smooth MuscleDisease Models, AnimalScleroderma, SystemicMice, Inbred C57BLMuscle, Smooth, VascularMale

Stichwörter der Autor:innen

hypoxic pulmonary vasoconstrictionpulmonary hypertensiontype 2 inflammationvascular hyperresponsivenessvascular remodeling

Substanzen

Fos-Related Antigen-2Fosl2 protein, mouse

Autor:innen und Institutionen

  • Ludwig Boltzmann Institute for Lung Vascular Research Graz, Graz, Austria.
  • Otto Loewi Research Center, Lung Research Cluster, Medical University of Graz, Graz, Austria.
  • Division of Physiology and Pathophysiology, Otto Loewi Research Center, Medical University of Graz, Graz, Austria.
  • Jagiellonian Centre for Experimental Therapeutics, Jagiellonian University, Krakow, Poland.
  • Department of Infectious Diseases, Respiratory Medicine and Critical Care, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Institute for Lung Health, Cardio-Pulmonary Institute, German Center for Lung Research, Justus-Liebig-University Giessen, Giessen, Germany.

ORCID-Profile: Anna Birnhuber, Valentina Biasin, Jochen Wilhelm, Katharina Ahrens, Andrea Olschewski, Stefan Chlopicki, Leigh M Marsh, Christoph Tabeling

Förderung

  • European Respiratory Society (ERS)
  • Austrian Science Fund (FWF)
  • Austrian Science Fund FWF
  • Deutsche Forschungsgemeinschaft (DFG)

Zitieren

APA

Birnhuber, A., Biasin, V., Jain, P. P., Kwiatkowski, G., Boiarina, E., Wilhelm, J., Ahrens, K., Nagaraj, C., Olschewski, A., Witzenrath, M., Chlopicki, S., Marsh, L. M., Tabeling, C., & Kwapiszewska, G. (2025). Pulmonary vascular remodeling in Fra-2 transgenic mice is driven by type 2 inflammation and accompanied by pulmonary vascular hyperresponsiveness. American Journal of Physiology-Lung Cellular and Molecular Physiology, 328(3), L413-L429. https://doi.org/10.1152/ajplung.00274.2024

Vancouver

Birnhuber A, Biasin V, Jain PP, Kwiatkowski G, Boiarina E, Wilhelm J, et al. Pulmonary vascular remodeling in Fra-2 transgenic mice is driven by type 2 inflammation and accompanied by pulmonary vascular hyperresponsiveness. American Journal of Physiology-Lung Cellular and Molecular Physiology. 2025;328(3):L413-L429. doi:10.1152/ajplung.00274.2024

BibTeX
@article{Birnhuber2025,
  author = {Birnhuber, Anna and Biasin, Valentina and Jain, Pritesh P and Kwiatkowski, Grzegorz and Boiarina, Ekaterina and Wilhelm, Jochen and Ahrens, Katharina and Nagaraj, Chandran and Olschewski, Andrea and Witzenrath, Martin and Chlopicki, Stefan and Marsh, Leigh M and Tabeling, Christoph and Kwapiszewska, Grazyna},
  title = {Pulmonary vascular remodeling in Fra-2 transgenic mice is driven by type 2 inflammation and accompanied by pulmonary vascular hyperresponsiveness},
  journal = {American Journal of Physiology-Lung Cellular and Molecular Physiology},
  year = {2025},
  volume = {328},
  number = {3},
  pages = {L413--L429},
  doi = {10.1152/ajplung.00274.2024}
}
Kostenlos starten →